Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 1, 2014
Issued Date -
N/A
app pub date -
Jul 28, 2010
filing date -
Jul 28, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to the use of specific compounds of formula (I) and their pharmaceutically-acceptable salts: (Formula 1) (I) as a new family of protein kinase CK2 inhibitors; the invention also relates to the use of compounds of formula (I) for the preparation of pharmaceutical compositions for the prevention and/or treatment of disorders and/or diseases chosen amongst cancers; autoimmune and inflammatory diseases; infectious diseases; diabetes angiogenesis related disorders; retinopathies and cardiac hypertrophy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully